Clinical trial
Evaluate The Lipid-Lowering Efficacy and Safety of Vytorin in Comparison With Atorvastatin in Hypercholesterolaemic Patients With Coronary Artery Disease
NCT00442897 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluate The Lipid-Lowering Efficacy and Safety of Vytorin in Comparison With Atorvastatin in Hypercholesterolaemic Patients With Coronary Artery Disease
- Lead sponsor
- Organon and Co
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- October 31, 2008
- Enrollment
- 229 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.